The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1/2 study of the TORC1/2 inhibitor onatasertib combined with toripalimab in patients with advanced solid tumors: Cervical cancer cohort.
 
Li Yuan
No Relationships to Disclose
 
Pei Shu
No Relationships to Disclose
 
Xiaoyu Li
No Relationships to Disclose
 
Guiling Li
No Relationships to Disclose
 
Keqiang Zhang
No Relationships to Disclose
 
Lin Lai
No Relationships to Disclose
 
Jinsheng Hong
No Relationships to Disclose
 
Chu-Ying Huang
No Relationships to Disclose
 
Yongsheng Wang
No Relationships to Disclose
 
Hui Xie
Employment - Antengene
Travel, Accommodations, Expenses - Antengene (Inst)
 
Li Zheng
No Relationships to Disclose
 
Qi Zhou
No Relationships to Disclose